Clinical Trial Update: Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for HS-10542 in paroxysmal nocturnal hemoglobinuria, currently in Phase 1/2 and recruiting for safety and efficacy assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• HS-10542

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Phase 1, Phase 2 | Status: RECRUITING